Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jun-ichi Fukushima is active.

Publication


Featured researches published by Jun-ichi Fukushima.


Pathology International | 2007

Amplification of c-myc and cyclin D1 genes in primary and metastatic carcinomas of the liver.

Yoshihisa Takahashi; Susumu Kawate; Masato Watanabe; Jun-ichi Fukushima; Shigeo Mori; Toshio Fukusato

The c‐myc and cyclin D1 genes are included among the oncogenes the amplifications of which have been detected in cancers of various organs. However, there have been few reports on the amplification of both these genes in primary and metastatic liver carcinomas. In the present study, c‐myc and cyclin D1 gene amplification was examined in 76 primary and metastatic liver carcinomas using formalin‐fixed paraffin‐embedded tissue sections and a differential polymerase chain reaction procedure. c‐myc and cyclin D1 gene amplification was detected in 15 (33%) and two (4%) of 46 hepatocellular carcinomas (HCC), one (10%) and 0 (0%) of 10 intrahepatic cholangiocarcinomas (ICC), one (33%) and 0 (0%) of three combined hepatocellular and cholangiocarcinomas (HCCu2003+u2003ICC), and nine (56%) and three (19%) of 16 metastatic lesions to the liver from colorectal adenocarcinoma (MCA), respectively. The incidence of c‐myc amplification was significantly higher in MCA than in ICC (Pu2003= 0.023), and it tended to be higher in HCC than in ICC. These results indicate that the amplification of the c‐myc proto‐oncogene is not unusual in HCC and MCA, and its detection may have a useful diagnostic significance in differentiating ICC from MCA or HCC from ICC.


Pathology International | 2004

Sarcomatoid carcinoma with components of small cell carcinoma and undifferentiated carcinoma of the gallbladder.

Yoshihisa Takahashi; Jun-ichi Fukushima; Toshio Fukusato; Junji Shiga

We report a case of sarcomatoid carcinoma with components of small cell carcinoma and undifferentiated carcinoma of the gallbladder. An 84‐year‐old woman was admitted to our university hospital with right upper abdominal pain and back pain. Clinical diagnosis of a gallbladder tumor was made based on the findings of abdominal ultrasonography, computed tomography and endoscopic retrograde cholangiopancreatography, and a cholecystectomy was carried out. On gross examination a pedunculated polypoid tumor protruded into the lumen of the gallbladder. Histologically the tumor was composed of carcinomatous and sarcomatous components; the carcinomatous component consisted mainly of small cell carcinoma and undifferentiated carcinoma. In general, the carcinomatous component of sarcomatoid carcinoma of the gallbladder consists of adenocarcinoma, and there have only been two previously reported cases in which the carcinomatous component consisted of small cell carcinoma or undifferentiated carcinoma. Because the patients prognosis may be influenced by the peculiar carcinomatous component in such cases, it is important to accumulate case reports that clarify their clinicopathological features.


Pathology International | 2009

Plasmablastic lymphoma of the retroperitoneum in an HIV-negative patient

Yoshihisa Takahashi; Ippo Saiga; Jun-ichi Fukushima; Nobuhiko Seki; Naoya Sugimoto; Akiko Hori; Kenji Eguchi; Toshio Fukusato

Herein is reported a case of plasmablastic lymphoma (PBL) of the retroperitoneum in an HIV‐negative patient. This is the first reported case of PBL at this location and of PBL from Japan in the English‐language literature. A 76‐year‐old Japanese man was admitted to hospital with a chief complaint of right inguinal lymph node swelling. Lymph node biopsy indicated large tumor cells with both diffuse and cohesive growth patterns, and conspicuous tumor cell proliferation in lymph node sinuses. The initial pathological diagnosis was metastatic carcinoma. The patient died approximately 1u2003month after admission, and autopsy showed that the main lesion was a very large retroperitoneal mass. On histology diffusely proliferated plasmablast‐like or immunoblast‐like tumor cells were identified, which were positive on immunohistochemistry for CD138 and negative for B‐cell and epithelial markers. Approximately 90% of the tumor cells were positive for Ki‐67. Tumor cells were diffusely positive for EBV‐encoded small RNA on in situ hybridization. The autopsy findings suggested a diagnosis of PBL. Accordingly, PBL should be considered as a differential diagnosis when lymph node biopsy findings resemble those of the present patient.


Abdominal Imaging | 2005

Unusual imaging appearances of pancreatic serous cystadenoma: correlation with surgery and pathologic analysis

Koji Takeshita; K. Kutomi; Koichi Takada; Hiroshi Kohtake; Shigeru Furui; Tadahiro Takada; Jun-ichi Fukushima

BackgroundWe describe imaging and pathologic features of serous cystadenoma of the pancreas on multislice helical computed tomography CT (MS-CT) and surgical resection.MethodsRadiologic and pathologic features were analyzed in five patients. All patients underwent MS-CT and digital subtraction angiography (DSA), and four patients underwent magnetic resonance (MR) imaging. Preoperatively, three cases showed radiologic evidence of mainly solid appearance on MS-CT, and the suspected diagnoses were solid pancreatic tumors (patients 1–3). The other two cases showed radiologic evidence of macrocystic tumor of the pancreas, and the suspected diagnoses were mucinous cystic tumors (cases 4 and 5). All patients underwent surgery, and the diagnosis of serous cystadenoma was confirmed on pathologic examination.ResultsIn three cases that showed a solid appearance on MS-CT, a microcystic appearance was identified on microscopic examination, and the tumors were found to be hypervascular lesions on multiphasic contrast-enhanced CT and DSA. In cases 1 and 2, the lesions showed high intensity with internal septation on T2-weighted MR images. In two cases, the tumors were classified as a macrocystic variant of serous cystadenoma, and no mural nodules, papillary projections, or calcifications were seen in the tumors.ConclusionImaging appearance of serous cystadenoma on MS-CT is various and sometimes indistinguishable from that of solid tumor or mucinous cystic tumors of the pancreas. Imaging findings of hypervascularity and a well-marginated high-intensity lesion with internal septation on T2-weighted MR imaging may be crucial to identify serous cystadenoma that contains no visible cystic compartments on MS-CT.


Journal of Gastroenterology | 2005

Prevalence of ischemic enterocolitis in patients with acute pancreatitis

Yoshihisa Takahashi; Jun-ichi Fukushima; Toshio Fukusato; Junji Shiga; Fumihiko Tanaka; Tetsuo Imamura; Masashi Fukayama; Tohru Inoue; Seiichiro Shimizu; Shigeo Mori

BackgroundA considerable number of acute pancreatitis cases have been reported to be complicated by nonocclusive mesenteric ischemia. However, no reports have ever referred to the incidence of ischemic enterocolitis in patients with acute pancreatitis, using a series of autopsy cases. Here, we report our review of autopsy cases of patients with acute pancreatitis to examine the incidence of associated ischemic enterocolitis.MethodsThe intestinal and pancreatic slides of 48 autopsy cases of patients with acute pancreatitis were reviewed and the incidence of ischemic enterocolitis was determined. Clinical case records were also reviewed.ResultsThirteen (27%) of 48 autopsy cases of patients with acute pancreatitis were complicated by ischemic enterocolitis. The frequency of shock was significantly higher in patients with ischemic enterocolitis than in those without ischemic enterocolitis. The intestinal lesion was diffuse in many cases and gangrene was not an unusual finding.ConclusionsThe incidence of ischemic enterocolitis in patients with acute pancreatitis was much higher than that in the previous reports. Clinicians who treat patients with acute pancreatitis should consider ischemic enterocolitis as one of the frequent and severe complications of this condition.


Hepatology Research | 2013

Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma

Arisa Kumagai; Jun-ichi Fukushima; Hajime Takikawa; Toshio Fukuda; Toshio Fukusato

The aim of this study was to investigate the expression of farnesoid X receptor (FXR) in human hepatocellular carcinoma (HCC) tissues and cell lines and evaluate its clinicopathological significance.


Tumori | 2011

A case report of thyroid gland metastasis associated with lung metastasis from colon cancer

Keisuke Nakamura; Keijiro Nozawa; Yoshiko Aoyagi; Soichiro Ishihara; Keiji Matsuda; Jun-ichi Fukushima; Toshiaki Watanabe

Thyroid gland metastasis of malignant tumors is observed in 1.9% to 9.5% of histologically examined autopsy cases. Thyroid metastasis from colon cancer is extremely rare and the prognosis is poor. Here we report a case of lung metastasis and thyroid gland metastasis following sigmoid colon cancer surgery. In 2000, a 58-year-old woman underwent a sigmoid colectomy for sigmoid colon cancer. In 2005, a metastatic lung tumor was detected by chest CT. The patient underwent a partial thoracoscopic resection of the left lung in April 2005. On a CT scan taken 3 years and 4 months after the lung resection, a tumor mass was observed in the left lung and a low-absorption region with an unclear border was seen in the left lobe of the thyroid gland. Thyroid aspiration cytology showed adenocarcinoma, and a diagnosis of thyroid gland metastasis from sigmoid colon cancer was made. In April 2008 a subtotal thyroidectomy was performed. Following surgery, the patient underwent chemotherapy with mFOLFOX6 and bevacizumab. Nevertheless a number of lung metastases and expressions of lung metastasis were subsequently observed. Histopathological examination revealed a number of metastases of differentiated papillary adenocarcinoma in the thyroid gland from colon cancer.


Hepatology Research | 2005

Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis

Toshio Fukusato; Jun-ichi Fukushima; Junji Shiga; Yoshihisa Takahashi; Toshiyuki Nakano; Shiro Maeyama; Uchikoshi Masayuki; Makoto Ohbu; Toshiharu Matsumoto; Koji Matsumoto; Hiroshi Hano; Michiie Sakamoto; Fukuo Kondo; Akio Komatsu; Takashi Ishikawa; Hiroo Ohtake; Hajima Takikawa; Kenichi Yoshimura


Internal Medicine | 2010

Carcinosarcoma of the Liver

Hideaki Goto; Atsushi Tanaka; Fukuo Kondo; Koji Takeshita; Ikuo Nagashima; Naoko Hanawa; Mitsuhiko Aiso; Yoriyuki Takamori; Kenichiro Kato; Yoshihisa Takahashi; Jun-ichi Fukushima; Shigeru Furui; Toshio Fukusato; Takehide Asano; Hajime Takikawa


Pathology Research and Practice | 2006

Adenomyoma with goblet and Paneth cells of the ileum

Yoshihisa Takahashi; Jun-ichi Fukushima; Toshio Fukusato; Shigeo Mori

Collaboration


Dive into the Jun-ichi Fukushima's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge